Highview Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.52M | Buy |
5,793
+85
| +1% | +$66.3K | 1.74% | 15 |
|
|
2025
Q1 | $4.71M | Sell |
5,708
-1,363
| -19% | -$1.13M | 1.97% | 15 |
|
|
2024
Q4 | $5.46M | Buy |
7,071
+308
| +5% | +$238K | 2.1% | 14 |
|
|
2024
Q3 | $5.99M | Buy |
6,763
+181
| +3% | +$160K | 2.44% | 10 |
|
|
2024
Q2 | $5.96M | Buy |
6,582
+73
| +1% | +$66.1K | 2.48% | 10 |
|
|
2024
Q1 | $5.06M | Sell |
6,509
-201
| -3% | -$156K | 2.28% | 9 |
|
|
2023
Q4 | $3.91M | Buy |
6,710
+311
| +5% | +$181K | 2.08% | 12 |
|
|
2023
Q3 | $3.44M | Sell |
6,399
-69
| -1% | -$37.1K | 1.97% | 13 |
|
|
2023
Q2 | $3.03M | Buy |
6,468
+21
| +0.3% | +$9.85K | 1.63% | 14 |
|
|
2023
Q1 | $2.21M | Sell |
6,447
-2,236
| -26% | -$768K | 1.28% | 17 |
|
|
2022
Q4 | $3.18M | Buy |
8,683
+210
| +2% | +$76.8K | 1.93% | 12 |
|
|
2022
Q3 | $2.74M | Buy |
8,473
+712
| +9% | +$230K | 2.03% | 12 |
|
|
2022
Q2 | $2.52M | Sell |
7,761
-515
| -6% | -$167K | 1.93% | 13 |
|
|
2022
Q1 | $2.37M | Buy |
8,276
+2,405
| +41% | +$689K | 1.52% | 15 |
|
|
2021
Q4 | $1.62M | Buy |
+5,871
| New | +$1.62M | 1.05% | 22 |
|